Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.natcopharma.co.in | |
Market Cap | 15,202.85 Cr. | |
Enterprise Value(EV) | 14,821.55 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 45.51 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 18.65 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 37.43 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 284.15 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 2.99 | Calculated using Price: 848.80 |
Dividend Yield | 0.65 | Period Ending 2023-03 |
No. of Shares Subscribed | 17.91 Cr. | 179,109,870 Shares |
FaceValue | 2 | |
About Natco Pharma Ltd. | ||
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry. |
1 Day |
|
-0.08% |
1 Week |
|
-4.08% |
1 Month |
|
-3.20% |
3 Month |
|
+35.39% |
6 Month |
|
+54.57% |
1 Year |
|
+33.64% |
2 Year |
|
-5.07% |
5 Year |
|
+7.70% |
10 Year |
|
+585.51% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 15.90 | 14.41 | 33.21 | 29.70 | 19.75 | 12.71 | 11.27 | 4.06 | 15.66 | |
Return on Capital Employed (%) | 14.89 | 17.49 | 39.21 | 35.28 | 23.71 | 14.82 | 13.99 | 4.86 | 18.06 | |
Return on Assets (%) | 9.69 | 9.58 | 23.43 | 23.05 | 16.02 | 10.30 | 9.43 | 3.43 | 13.29 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 726 | 846 | 1,296 | 1,649 | 3,072 | 3,489 | 3,774 | 4,122 | 4,264 | 4,874 | |
Non Curr. Liab. | 151 | 119 | 28 | 38 | 47 | 83 | 118 | 143 | 135 | 101 | |
Curr. Liab. | 312 | 414 | 493 | 627 | 592 | 729 | 685 | 526 | 710 | 683 | |
Minority Int. | 7 | 5 | 5 | 4 | 4 | 2 | 11 | 2 | |||
Equity & Liab. | 1,196 | 1,384 | 1,822 | 2,318 | 3,715 | 4,303 | 4,588 | 4,792 | 5,109 | 5,657 | |
Non Curr. Assets | 828 | 901 | 985 | 1,230 | 1,584 | 1,956 | 2,262 | 2,447 | 2,622 | 2,657 | |
Curr. Assets | 368 | 483 | 837 | 1,087 | 2,131 | 2,347 | 2,326 | 2,345 | 2,487 | 3,000 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,196 | 1,384 | 1,822 | 2,318 | 3,715 | 4,303 | 4,588 | 4,792 | 5,109 | 5,657 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 825 | 1,042 | 2,020 | 2,185 | 2,095 | 1,915 | 2,052 | 1,945 | 2,707 | 2,963 | |
Other Income | 15 | 10 | 14 | 40 | 130 | 107 | 106 | 99 | 129 | 90 | |
Total Income | 840 | 1,052 | 2,034 | 2,225 | 2,225 | 2,022 | 2,158 | 2,044 | 2,836 | 3,053 | |
Total Expenditure | -620 | -777 | -1,337 | -1,256 | -1,300 | -1,332 | -1,448 | -1,681 | -1,795 | -1,895 | |
PBIDT | 221 | 275 | 697 | 969 | 925 | 690 | 710 | 363 | 1,040 | 1,158 | |
Interest | -32 | -23 | -19 | -15 | -19 | -22 | -13 | -18 | -15 | -15 | |
Depreciation | -47 | -51 | -54 | -66 | -81 | -100 | -117 | -143 | -164 | -168 | |
Taxation | -2 | -48 | -140 | -192 | -182 | -111 | -137 | -32 | -147 | -161 | |
Exceptional Items | -15 | ||||||||||
PAT | 125 | 154 | 485 | 695 | 642 | 458 | 442 | 170 | 715 | 815 | |
Minority Interest | 4 | 1 | 1 | 1 | 2 | 3 | -2 | ||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 135 | 157 | 486 | 696 | 644 | 461 | 441 | 170 | 715 | 815 | |
Adjusted EPS | 8 | 9 | 28 | 38 | 35 | 25 | 24 | 9 | 39 | 45 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 144 | 93 | 112 | 346 | 464 | 669 | 417 | 299 | 47 | 849 | |
Cash Fr. Inv. | -109 | -115 | -176 | -299 | -1,116 | -612 | -167 | -103 | -5 | -477 | |
Cash Fr. Finan. | -35 | 29 | 154 | -48 | 651 | -51 | -251 | -186 | 35 | -363 | |
Net Change | 0 | 7 | 91 | -1 | -1 | 6 | -1 | 10 | 76 | 9 | |
Cash & Cash Eqvt | 10 | 12 | -74 | 24 | 22 | 28 | 20 | 26 | 111 | 132 |
Thu, 21 Sep 2023
Book Closure Book Closure for 40th Annual General Meeting |
Fri, 08 Sep 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release Legal Update |
Thu, 07 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Issue of Letter of confirmation of duplicate share certificate |
Mon, 25 Sep 2023 |
|
|
|
|
|